Merck
MRK
#54
Rank
HK$2.170 T
Marketcap
HK$878.70
Share price
2.73%
Change (1 day)
37.66%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): HK$57.00

According to Merck's latest financial reports the company's current EPS (TTM) is HK$57.27. an increase over its 2024 EPS that were of HK$52.95.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025HK$57.037.71%
2024HK$52.954308.46%
2023HK$1.20-97.32%
2022HK$44.8910.92%
2021HK$40.4784.68%
2020HK$21.91-27.2%
2019HK$30.1063.44%
2018HK$18.42151.11%
2017HK$7.33-54.58%
2016HK$16.1530.21%
2015HK$12.40-61.99%
2014HK$32.62180.51%
2013HK$11.63-31.82%
2012HK$17.066.62%
2011HK$16.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.26 52.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$56.41-1.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.65-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.38-48.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.38 214.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.27 96.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.18-71.75%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$27.11-52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$29.52-48.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$9.71-83.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel